Project Details
Description
Project Narrative
T myeloid-derived suppressor cells (MDSC) are responsible for supporting an environment that promotes
cancer progression and invasion. The goal of our project is to understand the mechanism underlying the
regulation of Tumor associate macrophage (TAM)/MDSC pro-tumor and tumor invasion by LILRB. The results
from this study will be used to design TAM/MDSC-targeted cancer immune therapies.
Status | Finished |
---|---|
Effective start/end date | 1/12/16 → 30/11/22 |
Funding
- National Cancer Institute: $435,587.00
- National Cancer Institute: $1,743,495.00
- National Cancer Institute: $1.00
- National Cancer Institute: $457,636.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.